Xuan Yang, Yalong Wang, Junke Zhao, Hehui Rong, Yujun Chen, Mengting Xiong, Xiaoxing Ye, Shihui Yu, Haiyan Hu. Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” Acta Pharmaceutica Sinica B 12 (2022) 3934–3951J. Acta Pharmaceutica Sinica B, 2023, 13(11): 4661-4663. DOI: 10.1016/j.apsb.2023.08.006
|
Citation:
|
Xuan Yang, Yalong Wang, Junke Zhao, Hehui Rong, Yujun Chen, Mengting Xiong, Xiaoxing Ye, Shihui Yu, Haiyan Hu. Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” Acta Pharmaceutica Sinica B 12 (2022) 3934–3951J. Acta Pharmaceutica Sinica B, 2023, 13(11): 4661-4663. DOI: 10.1016/j.apsb.2023.08.006
|
Xuan Yang, Yalong Wang, Junke Zhao, Hehui Rong, Yujun Chen, Mengting Xiong, Xiaoxing Ye, Shihui Yu, Haiyan Hu. Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” Acta Pharmaceutica Sinica B 12 (2022) 3934–3951J. Acta Pharmaceutica Sinica B, 2023, 13(11): 4661-4663. DOI: 10.1016/j.apsb.2023.08.006
|
Citation:
|
Xuan Yang, Yalong Wang, Junke Zhao, Hehui Rong, Yujun Chen, Mengting Xiong, Xiaoxing Ye, Shihui Yu, Haiyan Hu. Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” Acta Pharmaceutica Sinica B 12 (2022) 3934–3951J. Acta Pharmaceutica Sinica B, 2023, 13(11): 4661-4663. DOI: 10.1016/j.apsb.2023.08.006
|
DownLoad: